Time flies 🚀 Having entered the second half of 2024, we are taking this opportunity to look back at some of the fantastic events baby vc has organised this year! One of our highlights was with our recent DACH bootcamp sponsor HTGF | High-Tech Gründerfonds in June about “How to break into VC”! Thank you to the three speakers Sören, Anna and Stepan for providing us with invaluable insights ! Not only did the participants learn about their career paths into VC they also had the chance to learn first hand what the work in VC is all about by using a hands-on case study. Have a look at the pictures of the event at the HTGF office in Berlin! #babyvc #HTGF #partnership #diversityinvc
baby vc
Activités de placement pour compte propre
Paris, Ile de France 17 266 abonnés
Come for a VC bootcamp, stay for the community.
À propos
First bootcamp for those who aspire to join the venture capital community. A unique program during which a group of aspiring VCs meet those who make venture capital. They reveal to us behind the scenes, the secrets and the future of their profession. Have a look at our job board juste here: [https://airtable.com/shrePuJCHfJbTq17m/tblsaFTVJnUA2JWuY] Are you a venture capital fund or startup looking for a stellar addition to your team? Then add your job offer via this form [https://airtable.com/shrYcgd6zU6VAKlRL] to get access to our fellows and our community 🤓
- Site web
-
http://www.babyvc.co
Lien externe pour baby vc
- Secteur
- Activités de placement pour compte propre
- Taille de l’entreprise
- 51-200 employés
- Siège social
- Paris, Ile de France
- Type
- Établissement éducatif
- Fondée en
- 2019
- Domaines
- venture capital, bootcamp, fellowship, investment et startup
Lieux
-
Principal
Obtenir l’itinéraire
75000 Paris, Ile de France, FR
Employés chez baby vc
-
Maxime Paradis
Entrepreneur & Angel Investor | Forbes 30 Under 30 Europe
-
Hugo Jouan
Expansion & Strategy @ Cardino | VC Scout | ESCP MiM
-
Suprith Reddy
Founder Financially🚀 | Cofounder Ophigo (Acquired by Aareon) | Serial Tech Entrepreneur | Simplifying B2B Finance| baby vc
-
Henry Waldersee
vc @ earlybird | baby vc | mbi @ hsg
Nouvelles
-
💛 baby vc supports Italian Tech Week! 🙌🏻 In 2024, from September 25 to 27, OGR Torino will host Italy’s premier tech conference, with guests from Sequoia Capital and OpenAI, powered by Vento. 💥 No matter if you are a Founder, a VC, a student or a techie, the ITW will be a great opportunity to hear from outstanding professionals about their experiences and boost your network! The incredible lineup of speakers includes Douglas Leone from Sequoia Capital, Diego Piacentini, Chairman of Vento, Noam Ohana, Managing Director of Exor Ventures, and many others! ✨ A dedicated session on AI will be held on September 26, kicked off by an in-person speech by Sam Altman, Co- Founder and CEO of OpenAI, in conversation with John Elkann, CEO of Exor Ventures and Chairman of Stellantis & Ferrari. 🎟 Register for the event through the link in the first comment. The event is completely free, but tickets are limited! Hurry up and get yours 🥳 🤝 Will you be there? Leave a comment if you would like to have a chat with the Italian baby vc team in Turin! #ITW24 #italiantechweek #babyvc #VC #startups #innovation #Vento #Exor #OGR #Turin
-
-
The #TechBio 🔬 concluded the Masterclass series on Healthcare and Life Sciences 🧬. The key takeaways are available in the post bellow. 👇🏻 Thank you to our amazing speakers for the depth of insights provided. Manuel Grossmann (Founding Partner at Amino Collective) and Gregory Vladimer (Co-founder & Chief Scientific Officer of Allcyte which was acquired by Exscientia). 📝 📣 Starting on the first week of September, we will publish a set of 4 special editions of our Newsletter "What's up Tech?", one for each of the sessions covered in the Masterclass Series. The objective is to create a support to ensure the insights shared by the speakers are available to as many people as possible in a comprehensive and complete format. If you don't want to miss any, fill free to subscribe using the link in the comments. Stay tuned, and massive well done to the team for organising the sessions over the past few weeks! Ghita Benjelloun Benkacem Loubaba El Ayoubi Mariam Makhmutova Zeno Fox 🚀🔥
Last week, we hosted a session on TechBio session at baby vc. Manuel Grossmann from Amino Collective and Gregory Vladimer who co-founded Allcyte (acq. by Exscientia) joined us to explain the ins and outs of TechBio. We touched upon the fundamentals of TechBio startups, the European ecosystem, and important considerations when building and investing in the space. Key takeaways: ☂️ TechBio has become an umbrella term for founder-led, software- and engineering-driven biotech companies. It combines defining aspects of both tech and biotech companies. 📈 A TechBio company developing an internal therapeutic pipeline will undergo a fundamental change. It starts as a tech company building a software platform and becomes a biotech company upon creating an internal therapeutics pipeline, presenting a challenge to founders and investors. ♻️ Startups that combine a wet lab and a software platform should create a “lab in the loop”, where the platform and lab are tightly coupled to form a bi-directional feedback loop. ⚖️ TechBio companies need to create synergies and strike a balance between investing in the technology stack versus the internal pipeline, ensuring that each doesn’t starve. ❓ It is yet unclear whether companies should keep their assets as part of the main company or spin them off into subsidiaries. However, alignment between founders and investors is key. 🧐 Investors must understand whether a company will predominantly accrue value through its tech platform or scientific assets before they invest. 🇪🇺 Europe’s TechBio ecosystem is gaining traction, as demonstrated by the emergence of communities like Nucleate Bits in Bio and iGEM. Thanks to everyone who attended the session!
-
-
Our focus on #MedTech 🩺 investing last week has been a very insightful session once again. Read the key takeaways below 👇🏻. Thank you to Johannes Fischer from Wellington Partners Life Sciences, Jan Engels from HTGF | High-Tech Gründerfonds, and James Fok, MBA from Lifelight for sharing their expertise on these complex topics. It was useful to understand the various elements that investing in MedTech requires compared to other fields of Healthcare like Digital Health or Therapeutics. Get ready for next week as our final focus will be on #Techbio
Fundraising @Floww | London Stock Exchange Partner | Imperial College London & UCL graduate
Last week, baby vc hosted the #MedTech session as part of the Healthcare & Life Sciences Masterclass Series 🧬👇🏻 We were delighted to welcome Johannes Fischer from Wellington Partners Life Sciences, Jan Engels from HTGF | High-Tech Gründerfonds, and James Fok, MBA from Lifelight who discussed and shared with us the insights on the MedTech ecosystem in Europe, the importance of IP, regulatory hurdles for hardware, and the principle of investing in MedTech. 🩺🔬 Key takeaways: 💉Integrated diagnostics, robotics, and wearables/biosensors are leading growth sectors driven by demand for precision medicine, minimally invasive procedures, and personalised healthcare solutions. 🧨MedTech startups face two valleys of death: early-stage funding and technical feasibility, and later-stage challenges in clinical validation, regulatory approvals, and market acceptance. 🗂️A robust IP portfolio is crucial for VC investment in MedTech, providing a competitive edge, protection against imitation, and pathways for revenue beyond product sales. 💡The EU Medical Device Regulation (EU-MDR) complicates innovation with stringent requirements, prompting some European MedTech startups to focus on the U.S. go-to-market strategy. 💵Simple reimbursement strategies are vital for investor confidence, given the slow pace of business model innovation in MedTech due to regulatory and technical complexities. Thank you to everyone who joined the session. We look forward to seeing you again this Wednesday for the last session on #TechBio💛. CC Ghita Benjelloun Benkacem, Loubaba El Ayoubi, Zeno Fox
-
-
We are beyond excited to announce the new presidential team at baby vc! 💛 Join us in welcoming Giulia as our new President and Polina as our new Vice President! 🎉 Giulia joined baby vc by leading our expansion to Italy and driving growth in the country’s ecosystem as the Head of Italy. 🇮🇹 Polina started her journey as a fellow at baby vc and continued to make a significant impact as one of our Bootcamp Leads. A heartfelt thank you to Ghita and Justus for their outstanding work and dedication over the past year. Their contribution has been instrumental for baby vc’s growth, and we are grateful for their leadership! 🙌🏼 Starting today, Giulia and Polina will officially take on their new roles. We are excited to see where they will take baby vc next! 🚀
-
Post-quantum cryptography, 10-min delivery, low Earth orbit satellites, and many more... This Tuesday, we sent our loyal readers the 188th edition of our newsletter! 💌 This edition covered... 👇 💰 Fundraisings from Zepto, char.gy, iOnctura, Isar Aerospace, PQShield, and Vsquared Ventures 📲 The role of CVCs in Europe, Fisker filing for bankruptcy, and SaaS startup revenue growth decline 💼 Internship & Job offers from Cherry Ventures, OneRagtime, Initiator VC, World Fund, Ona Capital Privat SCR, Jet Investment A huge thanks to Anna Bassi, Niklas Urchs, Mehdi DOUYEB, Phillip Reimann, and Justine Pelisson 🧠 from the baby vc team who wrote this NL!👏 If you haven't read it yet:👉🏻 https://lnkd.in/eaESt84W #vc #venturecapital #technews
-
-
Thank you again to our expert, Dr. Anela Vukoja for this masterclass! We loved the session and left with a stronger understanding of what it means to be an investor in biotech, specifically in #therapeutics! 🙌🧬 Check out below for what we learned. For those who couldn't join us, we will publish a special newsletter later this year summarising the entire Healthcare and Life Science Masterclass Series.💛 This Wednesday, we will dive into the #MedTech ecosystem 🩺 with three field experts to understand this complex vertical and the investment landscape. Don't miss it!
The baby vc Healthcare & Life Sciences Masterclass Series continues in full swing 🚀, and we had the pleasure of learning more about investing in #Therapeutics. Last week, we were delighted to welcome Dr. Anela Vukoja for a very insightful session. As the COO at Apollo Health Ventures and a board member of companies such as Samsara Therapeutics, Cleara Biotech B.V., and Refoxy Pharma, Anela shared with us the fundamentals of investing in therapeutics, what is expected at an early stage, and what returns to anticipate when exiting such companies. 🧬💊 Here are some takeaways: 💰𝐑𝐢𝐬𝐤 𝐚𝐧𝐝 𝐂𝐨𝐬𝐭 𝐏𝐫𝐨𝐟𝐢𝐥𝐞: Each therapeutic modality has a different risk and cost profile, which should be considered in a VC investment thesis. For example, taking small molecules to clinical trials is less costly tℎan cell or gene therapies. 🎯 𝐈𝐧𝐯𝐞𝐬𝐭𝐨𝐫𝐬 𝐟𝐨𝐜𝐮𝐬 𝐨𝐧 𝐬𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐬𝐭𝐚𝐠𝐞𝐬 𝐨𝐟 𝐝𝐫𝐮𝐠 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭. Early-stage investors aim for convincing clinical proof of concept by phase 2 for potential exits. For example, POC in neurological diseases is often achieved sooner in rare diseases like ALS than in Parkinson's or Alzheimer's. 📊 𝐊𝐞𝐲 𝐢𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭 𝐜𝐫𝐢𝐭𝐞𝐫𝐢𝐚 𝐢𝐧𝐜𝐥𝐮𝐝𝐞: Mode of Action of the treatment, novelty and establishment of the target, availability of biomarkers, patient numbers needed to show an effect, translatability of MOA across models, ability to segment responsive patients, evidence of targeting disease drivers rather than secondary effects. 🔀 𝐄𝐚𝐫𝐥𝐲 𝐢𝐧𝐯𝐞𝐬𝐭𝐨𝐫𝐬 𝐩𝐫𝐞𝐟𝐞𝐫 𝐩𝐥𝐚𝐭𝐟𝐨𝐫𝐦 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬. This is due to diversified risk and multiple opportunities. However, companies with multiple assets approaching the clinic have higher financial demands than single-asset companies. 📝𝐓𝐢𝐦𝐢𝐧𝐠 𝐟𝐨𝐫 𝐟𝐢𝐥𝐢𝐧𝐠 𝐩𝐚𝐭𝐞𝐧𝐭𝐬 𝐢𝐬 𝐬𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐜. Filing later is better to maximize market protection, but it carries the risk of being copied. Thank you to everyone who joined the session. We look forward to welcoming you again this Wednesday to learn more about #MedTech and next week about #TechBio💛. CC Ghita Benjelloun Benkacem, Mariam Makhmutova, Zeno Fox
-
-
Liquid air energy storage, neuromodulation therapy, $1B for reliable AI solutions, Musk sued by shareholders, and many more... This Tuesday, we sent our loyal readers the 187th edition of our newsletter! 💌 This edition covered... 👇 💰 Fundraisings from Mistral AI, Cognigy, Amber Therapeutics, and Cisco’s global AI fund 📲 BeReal.’s acquisition by Voodoo, Tesla shareholders suing Musk, and Robinhood’s acquisition of Bitstamp Crypto Exchange 💼 Internship & Job offers from Cusp Capital, Newtree Impact, Crédit Agricole Création , Asset Partners, Outlier Ventures, Marble A huge thanks to Wiktoria Bulik and Justine Pelisson 🧠 from the baby vc team who wrote this NL!👏 If you haven't read it yet:👉🏻 https://lnkd.in/eU3d-YBb #vc #venturecapital #technews #babyvc
-
-
🇸🇪🇩🇰🇫🇮 Are you currently working in VC or would like to? Are you located in Sweden, Denmark or Finland? baby vc is going to the Nordics ✈️. If you answered yes to the two questions above, we invite you to join us in building this vibrand junior tech european community, as we currently have positions open for Head of Country/Region, bootcamp/community/partnership/content leads. If you would like to know more about these roles and be part of this adventures, contact Amicie Favre and Ghita Benjelloun Benkacem who are leading the expansion at [email protected] and you will hear from us in the next few days for interviews. 🔜 Hope to hear from you 👀 #VC #expansion #Nordics #Sweden #Denmark #Finland
-
Sustainable chemical production, radioisotopes, Shein's British IPO plan, and many more... This Tuesday, we sent our loyal readers the 186th edition of our newsletter! 💌 This edition covered... 👇 💰 Fundraisings from ITM Isotope Technologies Munich SE , Smart Energies, BioBTX, and Storyblok 📲 Creandum’s latest fund and SHEIN’s IPO plan 💼 Internship & Job offers from Techstars, Redstone, 14Peaks Capital, Serena Ventures, w3.fund, and Antler A huge thanks to Diana Munteh, Wiktoria Bulik, Tobias Schmitt, and Justine Pelisson 🧠 from the baby vc team who wrote this NL!👏 If you haven't read it yet:👉🏻 https://lnkd.in/eijRzfNR #vc #venturecapital #technews #babyvc
-